Skip to content

Development and Efficacy Testing of Respiratory Training Using the NU SpiroBreath Device on Respiratory Muscle Electromyography and Cardiorespiratory Physiological Variables in Pre-Elderly and Elderly Volunteers

Development and Efficacy Testing of Respiratory Training Using the NU SpiroBreath Device on Respiratory Muscle Electromyography and Cardiorespiratory Physiological Variables in Pre-Elderly and Elderly Volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260319002
Enrollment
32
Registered
2026-03-19
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory muscle weakness pneumonia Chronic obstructive pulmonary disease sarcopenia Respiratory muscle weakness pneumonia Chronic obstructive pulmonary disease sarcopenia

Interventions

Before starting the breathing exercise, volunteers sit and rest, performing normal breathing (Breathing Control) for 5 minutes. After that, volunteers will perform deep breathing exercise using NU Spi
Active Comparator Device,Active Comparator Device
NU SpiroBreath,NU SpiroBreath

Sponsors

Fundamental Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male or female aged 50-65 years old, has vital signs within the normal range. a. Normal temperature (36.5-37.5 oC) b. Normal heart rate (60-100 bpm) c. Normal respiratory rate (12-20 breaths/min) d. Normal blood pressure (SBP: 80-120 / DBP: 60-80 mmHg) 2. Voluntarily participate in the research project. 3. Have no history of chronic or acute respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, pneumonia, tuberculosis, and no conditions that contraindicate respiratory muscle training. 4. Be able to cooperate with the respiratory fitness training and can understand the process of the training and the research. 5. Be able to communicate by reading and writing in the Thai language.

Exclusion criteria

Exclusion criteria: 1. Cannot communicate by reading and writing in the Thai language. 2. Have history of chronic or acute respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, pneumonia, tuberculosis, and no conditions that contraindicate respiratory muscle training. 3. History of severe illness requiring hospitalization, such as patients who have been treated in the ICU. 4. Uncontrolled blood pressure; high blood pressure (SBP more than 140 in resting) and low blood pressure (SBP less than 90, DBP less than 60) 5. Have other health condition that can not complete the training protocol 6. Does not complete all steps/procedures of the research. 7. Loses contact or fails to attend scheduled appointments.

Design outcomes

Primary

MeasureTime frame
Diaphragm and anterior neck muscle (Sternocleidomastoid) activity, Respiratory muscle strength at first and at after end of the intervention Surface Electromyography, Maximum Inspiratory Pressure, Maximum Expiratory Pressure

Secondary

MeasureTime frame
Cardiopulmonary fitness at first and at after end of the intervention 6-minute walk test

Countries

Thailand

Contacts

Public ContactWeerapong Chidnok

Naresuan University

weerapongch@nu.ac.th0956326336

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026